Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Immunology

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1521-4141(200002)30:2<392::AID-IMMU392>3.0.CO;2-HPMID 10671194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal.

  1999cited by this paper
• Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

  1998cited by this paper
• CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand

  1998cited by this paper
• NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

  1998cited by this paper
• CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling.

  1998cited by this paper
• Amplification of tumor immunity by gene transfer of the co‐stimulatory 4‐1BB ligand: synergy with the CD28 co‐stimulatory pathway

  1998cited by this paper
• CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.

  1998cited by this paper
• Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.

  1997influential reference
• Accessory molecule and costimulation requirements for CD4 T cell response.

  1997cited by this paper
• Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

  1997cited by this paper
• 4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses

  1997cited by this paper
• Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.

  1997cited by this paper
• Costimulation of CD28- T lymphocytes by 4-1BB ligand.

  1997influential reference
• Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.

  1997cited by this paper
• Transfected Drosophila cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells.

  1996cited by this paper
• Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.

  1996cited by this paper
• Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.

  1996influential reference
• Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP

  1995influential reference
• Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

  1995cited by this paper
• CD40 ligand-transduced co-stimulation of T cells in the development of helper function

  1995cited by this paper
• Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.

  1995influential reference
• Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.

  1995cited by this paper
• ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages.

  1995cited by this paper
• Regulation of 4‐1BB expression by cell‐cell interactions and the cytokines, interleukin‐2 and interleukin‐4

  1995cited by this paper
• Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.

  1995cited by this paper
• Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.

  1995influential reference
• Moslecular and biological characterization of human 4‐1BB and its ligands

  1994cited by this paper
• 4‐1BB T‐cell antigen binds to mature B cells and macrophages, and costimulates anti‐μ‐primed splenic B cells

  1994cited by this paper
• Absence of B7-dependent responses in CD28-deficient mice.

  1994cited by this paper
• Humoral immune responses in CD40 ligand-deficient mice

  1994cited by this paper
• CD40 preferentially costimulates activation of CD4+ T lymphocytes.

  1994cited by this paper
• A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family.

  1993cited by this paper
• Inducible T cell antigen 4-1BB. Analysis of expression and function.

  1993cited by this paper
• Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1.

  1993cited by this paper
• Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements

  1992influential reference
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.

  1992cited by this paper
• CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.

  1991cited by this paper
• Role of the CD28 receptor in T-cell activation.

  1990cited by this paper
• cDNA sequences of two inducible T-cell genes.

  1989cited by this paper

• Functionally heterogeneous intratumoral CD4+CD8+ double-positive T cells can give rise to single-positive T cells

  2026cites this paper
• Soluble B7 and TNF family in colorectal cancer: Serum level, prognostic and treatment value.

  2025cites this paper
• Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity

  2024cites this paper
• p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation

  2024cites this paper
• Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy

  2022cites this paper
• Advances in immunotherapy for glioblastoma multiforme

  2022cites this paper
• Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents

  2021cites this paper
• CD137+ T-Cells: Protagonists of the Immunotherapy Revolution

  2021cites this paper
• The relevance of soluble CD137 in the regulation of immune responses and for immunotherapeutic intervention

  2020cites this paper
• OTT_A_282530 11869..11882

  2020cites this paper
• Emerging Targets of Immunotherapy in Gynecologic Cancer

  2020cites this paper
• A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model

  2019cites this paper
• The Role of Co-Stimulatory Molecules in Chagas Disease

  2018cites this paper
• Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.

  2017cites this paper
• The promise of 4-1BB (CD137) mediated immunomodulation and immunotherapy for viral diseases

  2017cites this paper
• Potential importance of B cells in aging and aging-associated neurodegenerative diseases

  2017cites this paper
• Control of CD4+ T cell responses by γδ T-APCs

  2016cites this paper
• Rôles de deux corécepteurs impliqués dans le maintien des cellules T mémoires CD8+ et la maturation des cellules dendritiques

  2016cites this paper
• Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers

  2016cites this paper
• Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model.

  2015cites this paper
• Introduction to Costimulation and Costimulatory Molecules

  2015cites this paper
• Lentiviral vector vaccines for T cell-mediated protection against influenza

  2014cites this paper
• Cancer Immunotherapy

  2013cites this paper
• CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy

  2013cites this paper
• The role of ICAM-1 mediated T cell:T cell interactions on CD8+ T cell effector function and differentiation

  2013cites this paper
• Immune co-signaling to treat cancer

  2013cites this paper
• A high throughput method for enrichment of natural killer cells and lymphocytes and assessment of in vitro cytotoxicity.

  2013cites this paper
• Suppression -Based β to Elaborate TGF- γ IFN- CD8 T Regulatory Cells Use

  2013cites this paper
• The Role of TRAF1 in Signaling Downstream of 4-1BB on CD8 T Cells

  2013cites this paper
• Targeted and Untargeted Fusion Proteins: Current Approaches to Cancer Immunotherapy

  2013cites this paper
• Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy

  2013influential citation
• Investigation of the activation of tumour-specific immune responses by gene therapy strategies using a model tumour antigen

  2012cites this paper
• Targeting Spatiotemporal Expression of CD137 on Tumor-infiltrating Cytotoxic T Lymphocytes as a Novel Strategy for Agonistic Antibody Therapy

  2012cites this paper
• Dissecting the Role of 4-1BB and its Ligand in Enhancing CD8 Effector and Memory T Cell Responses

  2012cites this paper
• Targeting of Costimulatory Molecules as a Therapeutic Approach in Inflammatory Bowel Disease

  2012cites this paper
• The combination of 4‐1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV‐specific T cell responses

  2011cites this paper
• Fighting with the Enemys Weapons? The Role of Costimulatory Molecules in HIV

  2011cites this paper
• Using monoclonal antibodies to stimulate antitumor cellular immunity

  2011cites this paper
• Fighting with the enemy's weapons? the role of costimulatory molecules in HIV.

  2011cites this paper
• progressive immunodeficiency in HIV-1 infection Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent

  2010cites this paper
• Sa-4-1bbl as a modulator of T effector to T regulatory cell conversion

  2010cites this paper
• The role of pulmonary dendritic cells in regulating the antigen-specific CD8 T cell response following influenza virus infection

  2010cites this paper
• Studies of human T cell costimulation: potential for the immunotherapy of cancer

  2010cites this paper
• The Role of Costimulation in the Persistence of the Immune Response in Kawasaki Disease

  2010cites this paper
• Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.

  2010cites this paper
• Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy in a Mouse Glioma Model

  2010cites this paper
• Co-signals in organ transplantation

  2010cites this paper
• Aus der Universitätsklinik für Kinder- und Jugendmedizin Tübingen Abteilung Kinderheilkunde I mit Poliklinik (Schwerpunkt: Allgemeine Pädiatrie, Hämatologie und Onkologie)

  2010cites this paper
• 4-1BB as a therapeutic target for human disease.

  2009cites this paper
• Targeting Immunological Synapse: New Horizons in Immunotherapy for Cancer

  2009cites this paper
• Therapeutic targets of the TNF superfamily

  2009cites this paper
• Anti-Leukemia Activity of MS-275 Histone Deacetylase Inhibitor Implicates 4-1BBL/4-1BB Immunomodulatory Functions

  2009cites this paper
• Costimulatory and coinhibitory receptors in anti‐tumor immunity

  2009cites this paper
• Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

  2008cites this paper
• The promise of 4‐1BB (CD137)‐mediated immunomodulation and the immunotherapy of cancer

  2008cites this paper
• Characterization and application of three novel monoclonal antibodies against human 4-1BB: distinct epitopes of human 4-1BB on lung tumor cells and immune cells.

  2007cites this paper
• Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors

  2007cites this paper
• Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.

  2007cites this paper
• Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.

  2007cites this paper
• CD137 ligand prevents the development of T‐helper type 2 cell‐mediated allergic asthma by interferon‐γ‐producing CD8+ T cells

  2007cites this paper
• Dependent Supereffector CD 8 T Cells That Become IL-7 Pathway to Induce Production of CD 134 Costimulation Couples the CD 137

  2007cites this paper
• Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.

  2007cites this paper
• 4‐1BB triggers IL‐13 production from T cells to limit the polarized, Th1‐mediated inflammation

  2007cites this paper
• CD8+ T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand1

  2007cites this paper
• Effector and memory CTL differentiation.

  2007cites this paper
• CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent1

  2007cites this paper
• Einfluss von anti-CD137 auf die Induktion und den Verlauf der Collagen-induzierten Arthritis

  2007cites this paper
• CD8 T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand

  2007cites this paper
• Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity

  2006cites this paper
• Genes, Transcripts and Proteins of CD137 Receptor and Ligand

  2006cites this paper
• 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.

  2006cites this paper
• CD137 in the Regulation of T Cell Response to Antigen

  2006cites this paper
• Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.

  2006cites this paper
• Approaches to studying costimulation of human antiviral T cell responses

  2006cites this paper
• Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells.

  2006cites this paper
• OX40 promotes differentiation of CD4+ T cells to effector cells

  2006cites this paper
• Exploiting 4-1BB Costimulation for Enhancing Antiviral Vaccination

  2006cites this paper
• Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells.

  2005cites this paper
• Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.

  2005cites this paper
• Absence of 4-1 BB Enhanced CD 4 T Cell Responsiveness in the Michael Croft

  2005cites this paper
• Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB1

  2005cites this paper
• Peptide-Specific CD8 T Regulatory Cells Use IFN-γ to Elaborate TGF-β-Based Suppression1

  2005cites this paper
• Production of Recombinant Human Trimeric CD137L (4-1BBL)

  2005cites this paper
• TNF/TNFR family members in costimulation of T cell responses.

  2005cites this paper
• Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression.

  2005cites this paper
• Cooperation between 4-1BB and ICOS in the Immune Response to Influenza Virus Revealed by Studies of CD28/ICOS-Deficient Mice1

  2005cites this paper
• Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation.

  2005influential citation
• Mice Revealed by Studies of CD 28 / ICOS-Deficient Immune Response to Influenza Virus Cooperation between 4-1 BB and ICOS in the

  2005cites this paper
• Modulation of antitumor responses by dendritic cells

  2004cites this paper
• Blockade of 4‐1BB (CD137)/4‐1BB ligand interactions increases allograft survival

  2004cites this paper
• This information is current as Responses Facilitate Robust CD 8 and CD 4 Recall 4-1 BB and OX 40 Act Independently to and

  2004cites this paper
• Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro.

  2004cites this paper
• Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.

  2004cites this paper
• Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival

  2004cites this paper
• Expression and function of 4‐1BB during CD4 versus CD8 T cell responses in vivo

  2004cites this paper
• Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis

  2004cites this paper
• New immunosuppressants with potential implication in multiple sclerosis.

  2004cites this paper
• Contribution à l'étude de l'immunosuppression et de l'induction de tolérance à l'allogreffe induite par des anticorps anti-CD28

  2004cites this paper
• Role of T cell costimulation in anti-viral immunity.

  2004cites this paper
• Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering

  2003cites this paper